Development of stable formulations for PLGA/PLA microsphere vaccines

Research in Immunology

Volumn 149, Issue 1, 1998, Pages 45-47

  Cleland, J L ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0039984797     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(98)80043-6     Document Type: Article

References (12)

1. Austin, P. E. et al. (1995), Ann. Emerg. Med., 25, 328-330.
2. Pihlajamki, H. et al. (1992), J. Bone Joint Surg., 74, 853-857.
3. Carel, J. C. et al. (1995), Eur. J. Endocrinol., 132, 699-704.
4. Schwendeman, S. et al. (1996), Dev. Biol. Stand., 87, 293-306.
5. Cleland, J. L. (1995), in "Vaccine Design: The Subunit Antigen Approach" (Powell, M. F. and Newman, M. J.) (pp. 439-462). Plenum Publishing, New York.
6. Cleland, J. L. et al. (1997), J. Controlled Rel., 47, 135-150.
7. Johnson, O. L. et al. (1996), Nature Med., 2, 795-799.
8. Cleland, J. L. & Jones, A. J. S. (1996), Pharm. Res., 13, 1462-1473.
9. Yang, J. and Cleland, J. L. (1997), J. Pharm Sci., 86, 908-914
10. Haigwood, N. L. et al. (1992), J. Virol., 66, 172-182.
11. Cleland, J. L. et al. (1998), J. Immunol., submitted for publication.
12. Cleland, J. L. et al. (1997), Proceed. Intern.Symp. Control. Rel Bioact. Mater., 24, 893-894.